Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Forum
  • Discovery
  • About Us
    • Our Coverage
    • Team

Cinclus Pharma

17.72 SEK

+2.55 %

Less than 1K followers

CINPHA

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Cinclus Pharma

Q3/24Q4/242024Q1/25Q2/25Q3/25Q4/252025
Revenue4.64.634.19.713.657.5
EBITDA-39.2-56.6-168.3-47.1-45.5-43.4
EBIT-39.2-56.9-169.6-47.5-45.9-44.1-62.0-199.6
EBIT-%-1,242.1 %-3,703.9 %-134.6 %-453.0 %-454.9 %-347.2 %
Profit before taxes-36.4-54.1-167.3-33.6-48.3-40.6-61.1-183.7
Net income-36.6-54.3-168.0-33.7-48.5-40.7-61.2-184.0
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.